Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats. Brakatselos C, Polissidis A, Ntoulas G, Asprogerakas MZ, et al. Neuropsychopharmacology 2024 Sep 6. doi: 10.1038/s41386-024-01977.

Read + Share

Amedeo Smart

Independent Medical Education

Brakatselos C, Polissidis A, Ntoulas G, Asprogerakas MZ, et al. Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats. Neuropsychopharmacology 2024 Sep 6. doi: 10.1038/s41386-024-01977.
PMID: 39242923